Key facts
| Price (PPV) | 116.40 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | irbésartan |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09CA04 |
| Manufacturer | PHI |
| Presentation | Boite de 30 |
| Nature | Médicament |
| Hospital price | 72.80 MAD |
| Data collected on | 9/8/2026 |
Indications
L’irbersartan est indiqué chez l’adulte dans le traitement de l’ hypertension artérielle essentielle. Il est également indiqué dans le traitement de l’atteinte rénale chez les patients adultes hypertendus diabétiques de type 2, dans le cadre de la prise en charge par un médicament antihypertenseur.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Arapro 150 mg (ZENITH PHARMA) contains the same active substance as Irphi 150 mg (Irbésartan) at the same strength, but in a different pack: Boite de 10 at 43.50 MAD, i.e. 4.35 MAD per unit against 3.88 MAD for Irphi 150 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Novortan 150 mg | NOVOPHARMA | Boite de 30 | 116 MAD | 3.87 / unit | — |
| Arapro 150 mg | ZENITH PHARMA | Boite de 30 | 116.40 MAD | 3.88 / unit | — |
| Avacor 150 mg | POLYMEDIC | Boite de 30 | 116.40 MAD | 3.88 / unit | — |
| Cardivel 150 mg | SPIMACO | Boite de 30 | 116.40 MAD | 3.88 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Arapro 150 mg | ZENITH PHARMA | Boite de 10 | 43.50 MAD | 4.35 / unit |
| Irvel 150 mg | AFRIC-PHAR | Boite de 14 | 60.90 MAD | 4.35 / unit |
| Vepran 150 mg | SOTHEMA | Boite de 14 | 60.90 MAD | 4.35 / unit |
| Icard 150 mg | COOPER PHARMA | Boite de 28 | 108.70 MAD | 3.88 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Irphi 150 mg
Irphi 150 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by PHI and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Irphi 150 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Irphi 150 mg
Answers to common questions from Moroccan patients about this drug.